News & Industry Bulletins

Monday, February 10, 2014

Dominion Diagnostics launches Kratom testing to address growing designer drug use trend

Dominion Diagnostics, a leading national provider of drug testing, medication monitoring, and clinical support services, launched new testing today that will detect Kratom use. Dominion’s Kratom assay will expand the company’s designer drug testing menu, which already includes detection of synthetic cannabinoids (Spice/K2) and synthetic cathinones (bath salts).

Tuesday, February 4, 2014

Dominion Diagnostics Commits High-Level Support for Leading Educational Events in Addiction Medicine and Behavioral Healthcare

Dominion Diagnostics is pleased to announce its renewed commitment to support education and advancement in addiction medicine and behavioral healthcare. For its second consecutive year, Dominion is the Series Thought Leadership Partner for the 2014 Addiction Professional Panel Series hosted by Vendome Healthcare Media.

Monday, April 22, 2013

Dominion Diagnostics to Support The One Fund Boston, Inc.

Dominion Diagnostics, a leading national provider of clinical drug testing and medication monitoring services, is uniting with other donors in the business community to raise funds for the victims of the Boston Marathon bombings. 

Tuesday, March 26, 2013

Dominion Diagnostics to Sponsor 2013 Addiction Professional Panel Series as Thought Leadership Partner

Dominion Diagnostics, a leading national provider of clinical drug testing and medication monitoring services, will sponsor a year-long series of regional educational Lunch’n’Learns hosted by Addiction Professional, a magazine published for the addiction treatment field by Vendome Healthcare Media.

Wednesday, October 3, 2012

Dominion Diagnostics launches new clinically relevant testing profile for bath salts detection

Leading national drug testing and medication monitoring company Dominion Diagnostics has launched new, more sensitive, and more relevant testing to detect synthetic cathinones or “bath salts” in urine.  Designed by Dominion’s Research and Development team, the test will detect five synthetic cathinones:  mephedrone, 3,4-methylendioxypyrovalerone (MDPV), methylone, butylone, and ethylone.   The testing, performed by liquid c

Tuesday, February 21, 2012

Dominion Diagnostics Celebrates 15 Years in Drug Monitoring, Clinical Support, and Education

Dominion Diagnostics, LLC, a leading national medication and substance use monitoring company, is celebrating its fifteenth year in business providing quality monitoring services, clinical support and education to improve patient outcomes in addiction treatment and pain management.